Advertisement

Preoperative factors influencing mortality and morbidity in peptic ulcer perforation

  • P. Sivaram
  • A. Sreekumar
Original Article

Abstract

Purpose

Perforated peptic ulcer is one of the most common surgical emergencies worldwide. With the improvement in medical therapy for peptic ulcers, the number of elective surgical procedures has come down. However, the incidence of perforated peptic ulcer is still increasing and remains as a substantial health problem with significant postoperative morbidity and mortality. This study aimed to find out the association between various preoperative and intraoperative factors with the postoperative mortality and morbidity in patients operated for peptic ulcer perforation.

Methods

This prospective observational study had a time based sample of 101 perforation peritonitis cases admitted to the surgical wards of a tertiary care center from February 2015 to January 2016 who underwent laparotomy, diagnosed to have peptic ulcer perforation and underwent simple closure with an omental patch. Data regarding age, gender, presenting complaints, time elapsed from the onset of symptoms to surgery, physical examination findings, comorbid diseases, laboratory and imaging findings, intraoperative findings, length of hospital stay, postoperative morbidity, and mortality were recorded and analyzed.

Results

Female gender, older age group, perforation surgery interval more than 36 h, and size of perforation more than 1 cm2 were found to be significant factors influencing postoperative mortality and morbidity. Postoperative morbidity was also associated with comorbid diseases. Abnormal renal function on presentation was identified as an additional risk factor for postoperative morbidity and longer hospital stay.

Conclusions

An understanding of these factors, identification of patients at risk and early intervention can help in reducing the postoperative morbidity and mortality in peptic ulcer perforation.

Keywords

Peptic ulcer perforation Perforation peritonitis Peptic ulcer Mortality—morbidity—peptic ulcer perforation 

Notes

Compliance with ethical standards

Conflict of interest

Sivaram P and Sreekumar A declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Funding sources

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

References

  1. 1.
    Mäkelä J, Laitinen S, Kairaluoma MI. Complications of peptic ulcer disease before and after the introduction of H2 receptor antagonists. Hepatogastroenterology. 1992;39:144–8.PubMedGoogle Scholar
  2. 2.
    Crofts TJ, Park KG, Steele RJ, et al. A randomized trial of nonoperative treatment for perforated peptic ulcer. New Eng J Med. 1989;320:970–3.CrossRefPubMedGoogle Scholar
  3. 3.
    Lau JY, Sung J, Hill C, et al. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion. 2011;84(2):102–13.CrossRefPubMedGoogle Scholar
  4. 4.
    Moller MH, Adamsen S, Thomsen RW, et al. Multicentre trial of a perioperative protocol to reduce mortality in patients with peptic ulcer perforation. Br J Surg. 2011;98(6):802–10.CrossRefPubMedGoogle Scholar
  5. 5.
    Zittel TT, Jehle EC, Becker HD. Surgical management of peptic ulcer disease today indication, technique and outcome. Langenbecks Arch Surg. 2000;385:84–96.CrossRefPubMedGoogle Scholar
  6. 6.
    Vaira D, Menegatti M, Miglioli M. What is the role of Helicobacter pylori in complicated ulcer disease? Gastroenterology. 1997;113:78–84.CrossRefGoogle Scholar
  7. 7.
    Casali JJ, Franzon O, Kruel NF, et al. Epidemiological analysis and use of rapid urease test in patients with perforated peptic ulcers. Rev Col Bras Cir. 2012;39:93–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Koçer B, Sürmeli S, Solak C, et al. Factors affecting mortality and morbidity in patients with peptic ulcer perforation. J Gastroenterol Hepatol. 2007;22:565–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Arveen S, Jagdish S, Kadambari D. Perforated peptic ulcer in South India: an institutional perspective. World J Surg. 2009;33(8):1600–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Gupta S, Kaushik R, Sharma R, et al. The management of large perforations of duodenal ulcers. BMC Surg. 2005;5:15.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Taş, Ülger BV, Önder A, et al. Risk factors influencing morbidity and mortality in perforated peptic ulcer disease. Ulus Cerrahi Derg 2014;31(1):20–5.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Surapaneni S, Rajkumar S, Vijaya bhaskar Reddy A. Perforation-operation time interval; an important mortality indicator in peptic ulcer perforation. J Clin Diagn Res. 2013;7(5):880–2.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Anbalakan K, Chua D, Pandya GJ, Shelat VG. Five year experience in management of perforated peptic ulcer and validation of common mortality risk prediction models—are existing models sufficient? A retrospective cohort study. Int J Surg. 2015;14:38–44.CrossRefPubMedGoogle Scholar
  14. 14.
    Testini M, Portincasa P, Piccinni G, et al. Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer. World J Gastroenterol. 2003;9:2338–40.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Boey J, Wong J, Ong GB. A prospective study of operative risk factors in perforated duodenal ulcers. Ann Surg. 1982;195(3):265–9.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Boey J, Choi SK, Poon A, et al. Risk stratification in perforated duodenal ulcers. A prospective validation of predictive factors. Ann Surg. 1987;205(1):22–6.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Kim JM, Jeong SH, Lee YJ, et al. Analysis of risk factors for postoperative morbidity in perforated peptic ulcer. J Gastric Cancer. 2012;12:26–35.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Noguiera C, Silva AS, Santos JN, et al. Perforated peptic ulcer: main factors of morbidity and mortality. World J Surg. 2003;27(7):782–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Montalvo-Jav´e EE, Corres-Sillas O, Athi´e-Guti´errez C. Factors associated with postoperative complications and mortality in perforated peptic ulcer. Cir Cir. 2011;79(2):141–8.Google Scholar
  20. 20.
    Hirsch IB, McGill JB. Role of insulin in management of surgical patients with diabetes mellitus. Diabetes Care. 1990;13:980–91.CrossRefPubMedGoogle Scholar
  21. 21.
    Stagnaro-Green A. Perioperative glucose control: does it really matter? Mt Sinai J Med. 1991;58:299–304.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Department of General SurgeryGovernment Medical CollegeThiruvananthapuramIndia

Personalised recommendations